Two-dose shot approved for Canadian adults.
Another COVID-19 vaccine has been approved for use in Canada.
Health Canada has authorized the two-dose Novavax Nuvaxovid vaccine for people aged 18 and older.
Clinical trails suggest the shot is 90 percent effective in protecting from symptomatic COVID-19 cases, and 100 percent effective in preventing severe disease, according to a release from the agency.
The vaccine's safety and effectiveness for children has not yet been determined.
Health Canada is recommending the two doses be administered 21 days apart.

Man Dead After Welland Shooting
Optimism Fading for Beluga Whales
Apartments Approved for Queenston Street
3 Arrested After NRP Find Cocaine
Police Looking for 2 Arsonists
Niagara Health Funding Gone Up: MPP
Wainfleet Taxes Rise Next Year
OPP Appeal for Drivers to Come Forward